
Topics
Meeting category
Date(s)
16 Feb 2021 - 17 Feb 2021
Program Language
English
Meeting type
Virtual
Organizer

COVID-19 Vaccine Development & Implementation Workshop 2021 - February Edition
Related Enduring Materials
Enduring Materials
Day 1 - Tuesday, 16 February
Session 1: Update Global Vaccine Situation & Critical Unknowns - 18:10
18:10 CET
Update on Current Vaccine Situation - An Overview
18:40 CET
Immune Responses in Current Vaccine Roll-out & Clinical Trials - The Impact on Durability and Transmission
Christiane Eberhardt, MD
Center for Vaccinology, University Hospitals and University of Geneva, Switzerland
19:05 CET
Vaccine Responses in the Key Populations (Elderly, Immunocompromised including HIV)
Session 2: Vaccine Development - 20:15
20:15 CET
Will SARS Cov-2 Become Resistant to Current Vaccines - Implications for Vaccine Development
Penny Moore, PhD
University of the Witwatersrand / National Institute for Communicable Diseases, South Africa
20:35 CET
Post Vaccination Antibody Testing: Its Role for Determining Level and Duration of Immunity
Benjamin Larimer, PhD
Assistant Professor, Department of Radiology and Associate Scientist, O'Neal Comprehensive Cancer Center at the University of Alabama Birmingham
20:55 CET
Real World Impact of Vaccine Rollout
Eyal Leshem, MD
Director of the Center for Travel Medicine and Tropical Diseases, Sheba Medical Center
21:15 CET
Determining Efficacy of COVID-19 Vaccines - Regulatory Perspective
Kirk Prutzman, PhD
Team Leader/Primary Reviewer in Office of Vaccines Research and Review (OVRR), FDA
Day 2 - Wednesday, 17 February
Session 3: What We Know About Protection - 18:05
18:05 CET
Vaccines - What Have We Shown and What Have We Yet to Show?
18:25 CET
How to Assess Protection Against Infection and Transmission After Vaccination?
Jakob Cramer, MD
Head of Clinical Development, Coalition for Epidemic Preparedness Innovations (CEPI)
18:45 CET
Reinfection and Protective Immunity After COVID Infection
19:05 CET
Optimizing Diagnostics for Post Vaccination Surveillance
Sanjat Kanjilal, MD, MPH
Brigham & Women’s Hospital, Harvard Medical School & Harvard Pilgrim Healthcare Institute, United States
19:25 CET
Adapting Diagnostics to Emerging Viral Variants
Session 4: Vaccine Has Arrived!!! - 20:30
20:30 CET
Optimizing Safety Surveillance for COVID-19 Vaccines
20:50 CET
Who to Vaccinate First to Get Maximal Public Health Benefit Out of the Vaccinations?
21:10 CET
Combating COVID-19 Vaccine Misinformation and Disinformation: A Clinician’s Perspective
Bisola O. Ojikutu, MD, MPH, FIDSA
Harvard Medical School, Harvard Center for AIDS Research, Brigham and Women’s Hospital, United States
21:30 CET
Vaccine Preparedness, Vaccine Hesitancy and Adverse Event Surveillance From a CDC Perspective
Overview
Committees
Support
Endorsers
Media